Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Corticosteroid Injections for Joint Pain Market Growth 2022-2028

  • LP 4802674
  • 107 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Corticosteroid Injections for Joint Pain will have significant change from previous year. According to our (LP Information) latest study, the global Corticosteroid Injections for Joint Pain market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Corticosteroid Injections for Joint Pain market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Corticosteroid Injections for Joint Pain market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Corticosteroid Injections for Joint Pain market, reaching US$ million by the year 2028. As for the Europe Corticosteroid Injections for Joint Pain landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Corticosteroid Injections for Joint Pain players cover Allergan, Pfizer, Sanofi, and Anika Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Corticosteroid Injections for Joint Pain market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Knee & Ankle

Hip Joint

Shoulder & Elbow

Facet Joints of the Spine

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Allergan

Pfizer

Sanofi

Anika Therapeutics

Ferring

Bioventus

Flexion Therapeutics

Zimmer Biomet

SEIKAGAKU

Chugai Pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Corticosteroid Injections for Joint Pain Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Corticosteroid Injections for Joint Pain by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Corticosteroid Injections for Joint Pain by Country/Region, 2017, 2022 & 2028

2.2 Corticosteroid Injections for Joint Pain Segment by Type

2.2.1 Knee & Ankle

2.2.2 Hip Joint

2.2.3 Shoulder & Elbow

2.2.4 Facet Joints of the Spine

2.2.5 Others

2.3 Corticosteroid Injections for Joint Pain Sales by Type

2.3.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2022)

2.3.2 Global Corticosteroid Injections for Joint Pain Revenue and Market Share by Type (2017-2022)

2.3.3 Global Corticosteroid Injections for Joint Pain Sale Price by Type (2017-2022)

2.4 Corticosteroid Injections for Joint Pain Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Corticosteroid Injections for Joint Pain Sales by Application

2.5.1 Global Corticosteroid Injections for Joint Pain Sale Market Share by Application (2017-2022)

2.5.2 Global Corticosteroid Injections for Joint Pain Revenue and Market Share by Application (2017-2022)

2.5.3 Global Corticosteroid Injections for Joint Pain Sale Price by Application (2017-2022)

3 Global Corticosteroid Injections for Joint Pain by Company

3.1 Global Corticosteroid Injections for Joint Pain Breakdown Data by Company

3.1.1 Global Corticosteroid Injections for Joint Pain Annual Sales by Company (2020-2022)

3.1.2 Global Corticosteroid Injections for Joint Pain Sales Market Share by Company (2020-2022)

3.2 Global Corticosteroid Injections for Joint Pain Annual Revenue by Company (2020-2022)

3.2.1 Global Corticosteroid Injections for Joint Pain Revenue by Company (2020-2022)

3.2.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Company (2020-2022)

3.3 Global Corticosteroid Injections for Joint Pain Sale Price by Company

3.4 Key Manufacturers Corticosteroid Injections for Joint Pain Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Corticosteroid Injections for Joint Pain Product Location Distribution

3.4.2 Players Corticosteroid Injections for Joint Pain Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Corticosteroid Injections for Joint Pain by Geographic Region

4.1 World Historic Corticosteroid Injections for Joint Pain Market Size by Geographic Region (2017-2022)

4.1.1 Global Corticosteroid Injections for Joint Pain Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Corticosteroid Injections for Joint Pain Annual Revenue by Geographic Region

4.2 World Historic Corticosteroid Injections for Joint Pain Market Size by Country/Region (2017-2022)

4.2.1 Global Corticosteroid Injections for Joint Pain Annual Sales by Country/Region (2017-2022)

4.2.2 Global Corticosteroid Injections for Joint Pain Annual Revenue by Country/Region

4.3 Americas Corticosteroid Injections for Joint Pain Sales Growth

4.4 APAC Corticosteroid Injections for Joint Pain Sales Growth

4.5 Europe Corticosteroid Injections for Joint Pain Sales Growth

4.6 Middle East & Africa Corticosteroid Injections for Joint Pain Sales Growth

5 Americas

5.1 Americas Corticosteroid Injections for Joint Pain Sales by Country

5.1.1 Americas Corticosteroid Injections for Joint Pain Sales by Country (2017-2022)

5.1.2 Americas Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022)

5.2 Americas Corticosteroid Injections for Joint Pain Sales by Type

5.3 Americas Corticosteroid Injections for Joint Pain Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Corticosteroid Injections for Joint Pain Sales by Region

6.1.1 APAC Corticosteroid Injections for Joint Pain Sales by Region (2017-2022)

6.1.2 APAC Corticosteroid Injections for Joint Pain Revenue by Region (2017-2022)

6.2 APAC Corticosteroid Injections for Joint Pain Sales by Type

6.3 APAC Corticosteroid Injections for Joint Pain Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Corticosteroid Injections for Joint Pain by Country

7.1.1 Europe Corticosteroid Injections for Joint Pain Sales by Country (2017-2022)

7.1.2 Europe Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022)

7.2 Europe Corticosteroid Injections for Joint Pain Sales by Type

7.3 Europe Corticosteroid Injections for Joint Pain Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Corticosteroid Injections for Joint Pain by Country

8.1.1 Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Country (2017-2022)

8.1.2 Middle East & Africa Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022)

8.2 Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Type

8.3 Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Corticosteroid Injections for Joint Pain

10.3 Manufacturing Process Analysis of Corticosteroid Injections for Joint Pain

10.4 Industry Chain Structure of Corticosteroid Injections for Joint Pain

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Corticosteroid Injections for Joint Pain Distributors

11.3 Corticosteroid Injections for Joint Pain Customer

12 World Forecast Review for Corticosteroid Injections for Joint Pain by Geographic Region

12.1 Global Corticosteroid Injections for Joint Pain Market Size Forecast by Region

12.1.1 Global Corticosteroid Injections for Joint Pain Forecast by Region (2023-2028)

12.1.2 Global Corticosteroid Injections for Joint Pain Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Corticosteroid Injections for Joint Pain Forecast by Type

12.7 Global Corticosteroid Injections for Joint Pain Forecast by Application

13 Key Players Analysis

13.1 Allergan

13.1.1 Allergan Company Information

13.1.2 Allergan Corticosteroid Injections for Joint Pain Product Offered

13.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allergan Main Business Overview

13.1.5 Allergan Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Corticosteroid Injections for Joint Pain Product Offered

13.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Corticosteroid Injections for Joint Pain Product Offered

13.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Anika Therapeutics

13.4.1 Anika Therapeutics Company Information

13.4.2 Anika Therapeutics Corticosteroid Injections for Joint Pain Product Offered

13.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Anika Therapeutics Main Business Overview

13.4.5 Anika Therapeutics Latest Developments

13.5 Ferring

13.5.1 Ferring Company Information

13.5.2 Ferring Corticosteroid Injections for Joint Pain Product Offered

13.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Ferring Main Business Overview

13.5.5 Ferring Latest Developments

13.6 Bioventus

13.6.1 Bioventus Company Information

13.6.2 Bioventus Corticosteroid Injections for Joint Pain Product Offered

13.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bioventus Main Business Overview

13.6.5 Bioventus Latest Developments

13.7 Flexion Therapeutics

13.7.1 Flexion Therapeutics Company Information

13.7.2 Flexion Therapeutics Corticosteroid Injections for Joint Pain Product Offered

13.7.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Flexion Therapeutics Main Business Overview

13.7.5 Flexion Therapeutics Latest Developments

13.8 Zimmer Biomet

13.8.1 Zimmer Biomet Company Information

13.8.2 Zimmer Biomet Corticosteroid Injections for Joint Pain Product Offered

13.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Zimmer Biomet Main Business Overview

13.8.5 Zimmer Biomet Latest Developments

13.9 SEIKAGAKU

13.9.1 SEIKAGAKU Company Information

13.9.2 SEIKAGAKU Corticosteroid Injections for Joint Pain Product Offered

13.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 SEIKAGAKU Main Business Overview

13.9.5 SEIKAGAKU Latest Developments

13.10 Chugai Pharma

13.10.1 Chugai Pharma Company Information

13.10.2 Chugai Pharma Corticosteroid Injections for Joint Pain Product Offered

13.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Chugai Pharma Main Business Overview

13.10.5 Chugai Pharma Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Corticosteroid Injections for Joint Pain Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Corticosteroid Injections for Joint Pain Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Knee & Ankle

Table 4. Major Players of Hip Joint

Table 5. Major Players of Shoulder & Elbow

Table 6. Major Players of Facet Joints of the Spine

Table 7. Major Players of Others

Table 8. Global Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)

Table 9. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2022)

Table 10. Global Corticosteroid Injections for Joint Pain Revenue by Type (2017-2022) & ($ million)

Table 11. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2022)

Table 12. Global Corticosteroid Injections for Joint Pain Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)

Table 14. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2022)

Table 15. Global Corticosteroid Injections for Joint Pain Revenue by Application (2017-2022)

Table 16. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2017-2022)

Table 17. Global Corticosteroid Injections for Joint Pain Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Corticosteroid Injections for Joint Pain Sales by Company (2020-2022) & (K Units)

Table 19. Global Corticosteroid Injections for Joint Pain Sales Market Share by Company (2020-2022)

Table 20. Global Corticosteroid Injections for Joint Pain Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Company (2020-2022)

Table 22. Global Corticosteroid Injections for Joint Pain Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Corticosteroid Injections for Joint Pain Producing Area Distribution and Sales Area

Table 24. Players Corticosteroid Injections for Joint Pain Products Offered

Table 25. Corticosteroid Injections for Joint Pain Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Corticosteroid Injections for Joint Pain Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Corticosteroid Injections for Joint Pain Sales Market Share Geographic Region (2017-2022)

Table 30. Global Corticosteroid Injections for Joint Pain Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Corticosteroid Injections for Joint Pain Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Corticosteroid Injections for Joint Pain Sales Market Share by Country/Region (2017-2022)

Table 34. Global Corticosteroid Injections for Joint Pain Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)

Table 37. Americas Corticosteroid Injections for Joint Pain Sales Market Share by Country (2017-2022)

Table 38. Americas Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2017-2022)

Table 40. Americas Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)

Table 41. Americas Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2022)

Table 42. Americas Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)

Table 43. Americas Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2022)

Table 44. APAC Corticosteroid Injections for Joint Pain Sales by Region (2017-2022) & (K Units)

Table 45. APAC Corticosteroid Injections for Joint Pain Sales Market Share by Region (2017-2022)

Table 46. APAC Corticosteroid Injections for Joint Pain Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2017-2022)

Table 48. APAC Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)

Table 49. APAC Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2022)

Table 50. APAC Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)

Table 51. APAC Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2022)

Table 52. Europe Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)

Table 53. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Country (2017-2022)

Table 54. Europe Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2017-2022)

Table 56. Europe Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)

Table 57. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2022)

Table 58. Europe Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)

Table 59. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Corticosteroid Injections for Joint Pain Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Corticosteroid Injections for Joint Pain

Table 69. Key Market Challenges & Risks of Corticosteroid Injections for Joint Pain

Table 70. Key Industry Trends of Corticosteroid Injections for Joint Pain

Table 71. Corticosteroid Injections for Joint Pain Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Corticosteroid Injections for Joint Pain Distributors List

Table 74. Corticosteroid Injections for Joint Pain Customer List

Table 75. Global Corticosteroid Injections for Joint Pain Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Corticosteroid Injections for Joint Pain Sales Market Forecast by Region

Table 77. Global Corticosteroid Injections for Joint Pain Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Corticosteroid Injections for Joint Pain Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Corticosteroid Injections for Joint Pain Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Corticosteroid Injections for Joint Pain Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Corticosteroid Injections for Joint Pain Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Corticosteroid Injections for Joint Pain Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Corticosteroid Injections for Joint Pain Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Corticosteroid Injections for Joint Pain Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Corticosteroid Injections for Joint Pain Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Corticosteroid Injections for Joint Pain Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Corticosteroid Injections for Joint Pain Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Corticosteroid Injections for Joint Pain Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Corticosteroid Injections for Joint Pain Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Corticosteroid Injections for Joint Pain Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Corticosteroid Injections for Joint Pain Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Corticosteroid Injections for Joint Pain Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Corticosteroid Injections for Joint Pain Revenue Market Share Forecast by Application (2023-2028)

Table 95. Allergan Basic Information, Corticosteroid Injections for Joint Pain Manufacturing Base, Sales Area and Its Competitors

Table 96. Allergan Corticosteroid Injections for Joint Pain Product Offered

Table 97. Allergan Corticosteroid Injections for Joint Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. Allergan Main Business

Table 99. Allergan Latest Developments

Table 100. Pfizer Basic Information, Corticosteroid Injections for Joint Pain Manufacturing Base, Sales Area and Its Competitors

Table 101. Pfizer Corticosteroid Injections for Joint Pain Product Offered

Table 102. Pfizer Corticosteroid Injections for Joint Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. Pfizer Main Business

Table 104. Pfizer Latest Developments

Table 105. Sanofi Basic Information, Corticosteroid Injections for Joint Pain Manufacturing Base, Sales Area and Its Competitors

Table 106. Sanofi Corticosteroid Injections for Joint Pain Product Offered

Table 107. Sanofi Corticosteroid Injections for Joint Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Sanofi Main Business

Table 109. Sanofi Latest Developments

Table 110. Anika Therapeutics Basic Information, Corticosteroid Injections for Joint Pain Manufacturing Base, Sales Area and Its Competitors

Table 111. Anika Therapeutics Corticosteroid Injections for Joint Pain Product Offered

Table 112. Anika Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. Anika Therapeutics Main Business

Table 114. Anika Therapeutics Latest Developments

Table 115. Ferring Basic Information, Corticosteroid Injections for Joint Pain Manufacturing Base, Sales Area and Its Competitors

Table 116. Ferring Corticosteroid Injections for Joint Pain Product Offered

Table 117. Ferring Corticosteroid Injections for Joint Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. Ferring Main Business

Table 119. Ferring Latest Developments

Table 120. Bioventus Basic Information, Corticosteroid Injections for Joint Pain Manufacturing Base, Sales Area and Its Competitors

Table 121. Bioventus Corticosteroid Injections for Joint Pain Product Offered

Table 122. Bioventus Corticosteroid Injections for Joint Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. Bioventus Main Business

Table 124. Bioventus Latest Developments

Table 125. Flexion Therapeutics Basic Information, Corticosteroid Injections for Joint Pain Manufacturing Base, Sales Area and Its Competitors

Table 126. Flexion Therapeutics Corticosteroid Injections for Joint Pain Product Offered

Table 127. Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Flexion Therapeutics Main Business

Table 129. Flexion Therapeutics Latest Developments

Table 130. Zimmer Biomet Basic Information, Corticosteroid Injections for Joint Pain Manufacturing Base, Sales Area and Its Competitors

Table 131. Zimmer Biomet Corticosteroid Injections for Joint Pain Product Offered

Table 132. Zimmer Biomet Corticosteroid Injections for Joint Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. Zimmer Biomet Main Business

Table 134. Zimmer Biomet Latest Developments

Table 135. SEIKAGAKU Basic Information, Corticosteroid Injections for Joint Pain Manufacturing Base, Sales Area and Its Competitors

Table 136. SEIKAGAKU Corticosteroid Injections for Joint Pain Product Offered

Table 137. SEIKAGAKU Corticosteroid Injections for Joint Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. SEIKAGAKU Main Business

Table 139. SEIKAGAKU Latest Developments

Table 140. Chugai Pharma Basic Information, Corticosteroid Injections for Joint Pain Manufacturing Base, Sales Area and Its Competitors

Table 141. Chugai Pharma Corticosteroid Injections for Joint Pain Product Offered

Table 142. Chugai Pharma Corticosteroid Injections for Joint Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 143. Chugai Pharma Main Business

Table 144. Chugai Pharma Latest Developments

List of Figures

Figure 1. Picture of Corticosteroid Injections for Joint Pain

Figure 2. Corticosteroid Injections for Joint Pain Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Corticosteroid Injections for Joint Pain Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Corticosteroid Injections for Joint Pain Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Corticosteroid Injections for Joint Pain Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Knee & Ankle

Figure 10. Product Picture of Hip Joint

Figure 11. Product Picture of Shoulder & Elbow

Figure 12. Product Picture of Facet Joints of the Spine

Figure 13. Product Picture of Others

Figure 14. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type in 2021

Figure 15. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2022)

Figure 16. Corticosteroid Injections for Joint Pain Consumed in Hospital Pharmacies

Figure 17. Global Corticosteroid Injections for Joint Pain Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 18. Corticosteroid Injections for Joint Pain Consumed in Retail Pharmacies

Figure 19. Global Corticosteroid Injections for Joint Pain Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 20. Corticosteroid Injections for Joint Pain Consumed in Online Pharmacies

Figure 21. Global Corticosteroid Injections for Joint Pain Market: Online Pharmacies (2017-2022) & (K Units)

Figure 22. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2022)

Figure 23. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application in 2021

Figure 24. Corticosteroid Injections for Joint Pain Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Company in 2021

Figure 26. Global Corticosteroid Injections for Joint Pain Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Geographic Region in 2021

Figure 28. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2017-2022)

Figure 29. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Country/Region in 2021

Figure 30. Americas Corticosteroid Injections for Joint Pain Sales 2017-2022 (K Units)

Figure 31. Americas Corticosteroid Injections for Joint Pain Revenue 2017-2022 ($ Millions)

Figure 32. APAC Corticosteroid Injections for Joint Pain Sales 2017-2022 (K Units)

Figure 33. APAC Corticosteroid Injections for Joint Pain Revenue 2017-2022 ($ Millions)

Figure 34. Europe Corticosteroid Injections for Joint Pain Sales 2017-2022 (K Units)

Figure 35. Europe Corticosteroid Injections for Joint Pain Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Corticosteroid Injections for Joint Pain Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue 2017-2022 ($ Millions)

Figure 38. Americas Corticosteroid Injections for Joint Pain Sales Market Share by Country in 2021

Figure 39. Americas Corticosteroid Injections for Joint Pain Revenue Market Share by Country in 2021

Figure 40. United States Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Corticosteroid Injections for Joint Pain Sales Market Share by Region in 2021

Figure 45. APAC Corticosteroid Injections for Joint Pain Revenue Market Share by Regions in 2021

Figure 46. China Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Country in 2021

Figure 53. Europe Corticosteroid Injections for Joint Pain Revenue Market Share by Country in 2021

Figure 54. Germany Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Corticosteroid Injections for Joint Pain Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue Market Share by Country in 2021

Figure 61. Egypt Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Corticosteroid Injections for Joint Pain Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Corticosteroid Injections for Joint Pain in 2021

Figure 67. Manufacturing Process Analysis of Corticosteroid Injections for Joint Pain

Figure 68. Industry Chain Structure of Corticosteroid Injections for Joint Pain

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390